Michael Conroy, VP of Compliance; Chris Daniel, Metabolic Associate Franchise Manager, Premier Medical Laboratory Services
Recent research has evidenced the bi-directional relationship between COVID-19 and diabetes and its correlation with increased risk and mortality; it is observed that about 20-30% of the COVID-19 fatalities were reported to be patients with diabetes. Scientists have further stated that there is a possibility for the novel coronavirus to even alter glucose metabolism, which could complicate preexisting diabetes or lead to newer mutations of the disease. At these crossroads, Premier Medical Laboratory Services has exclusively introduced to the US a predictive test for type 2 diabetes, in turn, improving patient outcomes.
The company’s DIABETESpredict™ proactively determines a patient’s type 2 diabetes genetic risk, effectively providing individualized lifestyle and diet recommendations for the prevention and management of type 2 diabetes and reducing the probability of severe COVID-19 infection or post-infection disease onset. More importantly, the DIABETESpredict™ test is expected to mark a new era in diabetes prevention and care.
Alongside their diabetes testing, PMLS’s cardiovascular panel, MDHeartPro, offers a more comprehensive look at a patient’s cardiovascular health than the standard lipid profile that is commonly ordered. Because many patients that have heart attacks and strokes have normal lipid levels, MDHeartPro includes tests that identify plaque buildup, lipid particle size, hereditary factors, and other advanced risk factors in addition to the standard lipid panel. With MDHeartPro physicians can take a more proactive approach for effective patient care.
As a CLIA and COLA regulated laboratory based in Greenville, SC, Premier Medical Laboratory Services (PMLS) excels at providing clinically meaningful medical results with all of their test offerings. From COVID-19 PCR and antigen testing, antibody testing, pharmacogenomics, toxicology, advanced cardiovascular testing, women’s health & wellness, and diabetes tests, all are performed under one roof with cutting-edge laboratory equipment that translates to a quick turnaround of results for physicians and patients. “With the increase in coronavirus cases, we have maximized our capacity to process tests (up to 300,000 tests per day), with 92% of test results provided in under 24 hours,” adds Michael Conroy, VP of Compliance.
With the recent increase in coronavirus cases, we have maximized our capacity to process tests (up to 300,000 tests per day), with 92% of their test results provided in under 24 hours
“We have also launched a large-scale surveillance of COVID-19 variants with Next Generation Sequencing to monitor SARS-CoV-2 genomic mutations here at the lab with automated sequencing and library prep equipment.”
In an effort to help other labs increase their testing capacity and efficiency, Premier Medical Laboratory Services has also introduced Virtual Lab, (an innovative COVID-19 testing solution to overcome laboratory infrastructure restrictions), which enables testing facilities to drastically increase their capacity in a matter of days. By utilizing their fully-automated robotic workflow with a testing capacity of 300,000 tests per day and team of 360 employees, including PhD scientists, Virtual Lab allows these facilities to bypass the need to purchase new equipment or endure waiting time of weeks or more for shipping, installation, and validation.
Along similar lines, PMLS’s sister company, Vessel Medical offers Lab in a Box, turnkey lab equipment that comes with everything needed for professional laboratory level diagnostics for COVID-19, Flu A and B, upper respiratory, STD/UTI, cancer risk screening, pharmacogenomics, and antibiotic resistance testing. Developed by leading scientists and technicians in partnership with Hamilton Company, Thermo Fisher, and Grenova, Lab in a Box enables a high capacity of onsite diagnostics for hospitals, expanding laboratories, schools, and large companies in need of quick and accurate testing results. With precision robotic instruments, lab in a box has high throughput liquid handling along with automated, custom-programmable pipetting that decreases human error and result turnaround time.
As an industry leader in molecular diagnostics, PMLS has an in-house research and development department, experienced laboratory staff, and a diligent customer care team to deliver the latest molecular diagnostic solutions with accuracy and reliability. Utilizing cutting edge equipment and one of the most advanced laboratory information systems, OnGen LIS, to generate easy to read one page test result reports, PMLS delivers customized reports for each client while communicating real-time results to physicians directly from their lab equipment. As a laboratory capable of processing hundreds of thousands of COVID-19 tests per month while increasing the testing capacity of other molecular diagnostic solutions without compromising accuracy or the turnaround time of results, PMLS is a top of the line medical diagnostics laboratory.